OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting Immunometabolism in Glioblastoma
Aditya Mohan, William H. Tomaszewski, Aden Haskell-Mendoza, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 27
Aditya Mohan, William H. Tomaszewski, Aden Haskell-Mendoza, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 27
Showing 1-25 of 27 citing articles:
Macrophage Reprogramming and Cancer Therapeutics: Role of iNOS-Derived NO
Khosrow Kashfi, Jasmine J. Kannikal, Niharika Nath
Cells (2021) Vol. 10, Iss. 11, pp. 3194-3194
Open Access | Times Cited: 146
Khosrow Kashfi, Jasmine J. Kannikal, Niharika Nath
Cells (2021) Vol. 10, Iss. 11, pp. 3194-3194
Open Access | Times Cited: 146
Glioblastoma Therapy: Past, Present and Future
Elena Obrador, Paz Moreno-Murciano, María Oriol‐Caballo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2529-2529
Open Access | Times Cited: 63
Elena Obrador, Paz Moreno-Murciano, María Oriol‐Caballo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2529-2529
Open Access | Times Cited: 63
Multispectral fluorine-19 MRI enables longitudinal and noninvasive monitoring of tumor-associated macrophages
Davide Croci, Rui Santalla Méndez, Sebastian Temme, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 667
Open Access | Times Cited: 40
Davide Croci, Rui Santalla Méndez, Sebastian Temme, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 667
Open Access | Times Cited: 40
Glioblastoma Metabolism: Insights and Therapeutic Strategies
Chloé Bernhard, Damien Reita, Sophie Martin, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9137-9137
Open Access | Times Cited: 31
Chloé Bernhard, Damien Reita, Sophie Martin, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9137-9137
Open Access | Times Cited: 31
Integrating Multi-Omics Analysis for Enhanced Diagnosis and Treatment of Glioblastoma: A Comprehensive Data-Driven Approach
Amir Barzegar Behrooz, Hamid Latifi‐Navid, Simone C. da Silva Rosa, et al.
Cancers (2023) Vol. 15, Iss. 12, pp. 3158-3158
Open Access | Times Cited: 19
Amir Barzegar Behrooz, Hamid Latifi‐Navid, Simone C. da Silva Rosa, et al.
Cancers (2023) Vol. 15, Iss. 12, pp. 3158-3158
Open Access | Times Cited: 19
Targeted Arginine Metabolism Therapy: A Dilemma in Glioma Treatment
Xiaoshuang Hou, Sui Chen, Po Zhang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 24
Xiaoshuang Hou, Sui Chen, Po Zhang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 24
The functional role of p38 MAPK pathway in malignant brain tumors
Nathália Grave, Thamiris Becker Scheffel, Fernanda Fernandes Cruz, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 24
Nathália Grave, Thamiris Becker Scheffel, Fernanda Fernandes Cruz, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 24
Glioblastoma: Relationship between Metabolism and Immunosuppressive Microenvironment
Ainhoa Hernández, Marta Domènech, Ana M Muñoz‐Mármol, et al.
Cells (2021) Vol. 10, Iss. 12, pp. 3529-3529
Open Access | Times Cited: 31
Ainhoa Hernández, Marta Domènech, Ana M Muñoz‐Mármol, et al.
Cells (2021) Vol. 10, Iss. 12, pp. 3529-3529
Open Access | Times Cited: 31
Immunometabolism – The Role of Branched-Chain Amino Acids
Berkay Yahsi, Gürcan Günaydın
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 19
Berkay Yahsi, Gürcan Günaydın
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 19
The Tumor Immune Microenvironment in Primary CNS Neoplasms: A Review of Current Knowledge and Therapeutic Approaches
Anita Kalluri, Pavan P. Shah, Michael Lim
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2020-2020
Open Access | Times Cited: 11
Anita Kalluri, Pavan P. Shah, Michael Lim
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2020-2020
Open Access | Times Cited: 11
Metabolic shifts in glioblastoma: unraveling altered pathways and exploring novel therapeutic avenues
D.V. Malhotra, Reema Gabrani
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
D.V. Malhotra, Reema Gabrani
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
A2A receptor antagonist 4-(2-((6-Amino-9-ethyl-8-(furan-2-yl)-9H-purin-2-yl)amino)ethyl)phenol, a promising adenosine derivative for glioblastoma treatment
Akshaya Murugesan, Aleksei N. Smirnov, Anxo Vila Alonso, et al.
European Journal of Pharmaceutical Sciences (2025), pp. 107039-107039
Open Access
Akshaya Murugesan, Aleksei N. Smirnov, Anxo Vila Alonso, et al.
European Journal of Pharmaceutical Sciences (2025), pp. 107039-107039
Open Access
Diversity of metabolic features and relevance to clinical subtypes of gliomas
Pushan Dasgupta, Vinay K. Puduvalli
Seminars in Cancer Biology (2025)
Closed Access
Pushan Dasgupta, Vinay K. Puduvalli
Seminars in Cancer Biology (2025)
Closed Access
Glioblastoma stem cell metabolism and immunity
Joseph Hawly, Micaela G. Murcar, Alejandro Schcolnik‐Cabrera, et al.
Cancer and Metastasis Reviews (2024)
Closed Access | Times Cited: 3
Joseph Hawly, Micaela G. Murcar, Alejandro Schcolnik‐Cabrera, et al.
Cancer and Metastasis Reviews (2024)
Closed Access | Times Cited: 3
Integrating Multi-Omics Analysis for Enhanced Diagnosis and Treatment of Glioblastoma: A Comprehensive Data-Driven Approach
Amir Barzegar Behrooz, Hamid Latifi‐Navid, Simone C. da Silva Rosa, et al.
(2023)
Open Access | Times Cited: 8
Amir Barzegar Behrooz, Hamid Latifi‐Navid, Simone C. da Silva Rosa, et al.
(2023)
Open Access | Times Cited: 8
Terahertz Time-Domain Spectroscopy of Glioma Patient Blood Plasma: Diagnosis and Treatment
О. П. Черкасова, Denis A. Vrazhnov, Anastasia Knyazkova, et al.
Applied Sciences (2023) Vol. 13, Iss. 9, pp. 5434-5434
Open Access | Times Cited: 7
О. П. Черкасова, Denis A. Vrazhnov, Anastasia Knyazkova, et al.
Applied Sciences (2023) Vol. 13, Iss. 9, pp. 5434-5434
Open Access | Times Cited: 7
Tackling the Behavior of Cancer Cells: Molecular Bases for Repurposing Antipsychotic Drugs in the Treatment of Glioblastoma
Michele Persico, Claudia Abbruzzese, Silvia Matteoni, et al.
Cells (2022) Vol. 11, Iss. 2, pp. 263-263
Open Access | Times Cited: 12
Michele Persico, Claudia Abbruzzese, Silvia Matteoni, et al.
Cells (2022) Vol. 11, Iss. 2, pp. 263-263
Open Access | Times Cited: 12
Immune Microenvironment Landscape in CNS Tumors and Role in Responses to Immunotherapy
Hinda Najem, Mustafa Khasraw, Amy B. Heimberger
Cells (2021) Vol. 10, Iss. 8, pp. 2032-2032
Open Access | Times Cited: 14
Hinda Najem, Mustafa Khasraw, Amy B. Heimberger
Cells (2021) Vol. 10, Iss. 8, pp. 2032-2032
Open Access | Times Cited: 14
Insight into the transcription factors regulating Ischemic stroke and glioma in response to shared stimuli
Arshi Waseem, Summya Rashid, Khalid Rashid, et al.
Seminars in Cancer Biology (2023) Vol. 92, pp. 102-127
Closed Access | Times Cited: 5
Arshi Waseem, Summya Rashid, Khalid Rashid, et al.
Seminars in Cancer Biology (2023) Vol. 92, pp. 102-127
Closed Access | Times Cited: 5
Amino Acid Deprivation in Glioblastoma: The Role in Survival and the Tumour Microenvironment—A Narrative Review
Kevin Du, Leila Grocott, Giulio Anichini, et al.
Biomedicines (2024) Vol. 12, Iss. 11, pp. 2481-2481
Open Access | Times Cited: 1
Kevin Du, Leila Grocott, Giulio Anichini, et al.
Biomedicines (2024) Vol. 12, Iss. 11, pp. 2481-2481
Open Access | Times Cited: 1
Metabolic checkpoints in glioblastomas: targets for new therapies and non-invasive detection
Wenhao Li, Zhihao Wang, Siliang Chen, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Wenhao Li, Zhihao Wang, Siliang Chen, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Untargeted metabolomics profiling in a mouse model of lung cancer treated with thermal ablation
Haoyue Pang, Kaiwen Hu, Fuyao Li, et al.
Bioengineered (2022) Vol. 13, Iss. 4, pp. 11258-11268
Open Access | Times Cited: 4
Haoyue Pang, Kaiwen Hu, Fuyao Li, et al.
Bioengineered (2022) Vol. 13, Iss. 4, pp. 11258-11268
Open Access | Times Cited: 4
Development of a novel glycolysis-related genes signature for isocitrate dehydrogenase 1-associated glioblastoma multiforme
Xiaomin Cai, Zheng Chen, Caiquan Huang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 4
Xiaomin Cai, Zheng Chen, Caiquan Huang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 4
Advances in bioengineered CAR T/NK cell therapy for glioblastoma: Overcoming immunosuppression and nanotechnology‐based strategies for enhanced CAR T/NK cell therapy
Nasim Dana, Arezou Dabiri, Majed Bahri Najafi, et al.
Bioengineering & Translational Medicine (2024)
Open Access
Nasim Dana, Arezou Dabiri, Majed Bahri Najafi, et al.
Bioengineering & Translational Medicine (2024)
Open Access
Monitoring response to a clinically relevant IDH inhibitor in glioma—Hyperpolarized 13C magnetic resonance spectroscopy approaches
Donghyun Hong, Yaewon Kim, Chandrasekhar Mushti, et al.
Neuro-Oncology Advances (2023) Vol. 5, Iss. 1
Open Access | Times Cited: 1
Donghyun Hong, Yaewon Kim, Chandrasekhar Mushti, et al.
Neuro-Oncology Advances (2023) Vol. 5, Iss. 1
Open Access | Times Cited: 1
